ENTRY       D04458                      Drug
NAME        Hydralazine polistirex (USAN)
CLASS       Cardiovascular agent
             DG03231  Antihypertensive
             DG02046  Hydrazinophthalazine derivative
            Metabolizing enzyme substrate
             DG02928  NAT substrate
            Metabolizing enzyme inhibitor
             DG01645  CYP2D6 inhibitor
REMARK      ATC code: C02DB02
            Chemical structure group: DG00261
            Product (DG00261): D01302<JP/US>
EFFICACY    Antihypertensive
COMMENT     Hydrazinophthalazine derivative
TARGET      AOC3 [HSA:8639] [KO:K00276]
METABOLISM  Enzyme: NAT [HSA:9 10]
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C02 ANTIHYPERTENSIVES
               C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
                C02DB Hydrazinophthalazine derivatives
                 C02DB02 Hydralazine
                  D04458  Hydralazine polistirex (USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG03231  Antihypertensive
               DG00261  Hydralazine
                D04458  Hydralazine polistirex
              DG02046  Hydrazinophthalazine derivative
               DG00261  Hydralazine
                D04458  Hydralazine polistirex
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00261  Hydralazine
                D04458  Hydralazine polistirex
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00261  Hydralazine
                D04458  Hydralazine polistirex
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Amine oxidases
                AOC3
                 D04458  Hydralazine polistirex (USAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04458
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG03231  Antihypertensive
               DG00261  Hydralazine
              DG02046  Hydrazinophthalazine derivative
               DG00261  Hydralazine
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00261  Hydralazine
             Metabolizing enzyme inhibitor
              DG01645  CYP2D6 inhibitor
               DG00261  Hydralazine
DBLINKS     PubChem: 47206322
///
